Using superb vascular imaging to check pancreatic cysts
Part of Cancer clinical trials.
This trial tests a new imaging technique called SMI (Superb Vascular Imaging) to better understand pancreatic cysts that are not yet diagnosed. It may help doctors decide if a cyst is harmless or needs treatment, avoiding unnecessary procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a pancreatic cyst that needs more testing with a special microscope (nCLE).
- Your cyst is larger than 15 mm (about the size of a pea) and has a space inside at least 5 mm wide.
- You are registered with or covered by the French National Health Service.
- You speak French and can sign a consent form to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to look at EUS images and other information to better understand and manage pancreatic cysts. It aims to help doctors tell different types of cysts apart so they can choose the best treatment for you.
This trial uses a special ultrasound technique (Superb Microvascular Imaging) to better understand the material inside a type of pancreatic cyst called a PIMPT. It may help doctors decide if the cyst is dangerous without needing more invasive tests.
This study tests two new ultrasound techniques to better tell apart pancreatic cancer from other solid growths in the pancreas. If you have a solid pancreas mass, the results could help doctors choose the most appropriate treatment without unnecessary surgery.
This trial tests a special camera (confocal laser endomicroscopy) used during an ultrasound-guided needle biopsy to help tell what type of pancreatic cyst is present. It may help doctors decide faster whether surgery is needed.
This study tests a new lab test called PanCystPro that looks at fluid taken from a pancreatic cyst during an endoscopic ultrasound. It aims to help doctors better manage your condition.
This study compares different ways to monitor pancreatic cysts and also measures blood or other test markers to see which approach is more helpful. It may help patients by finding the safest, most effective way to track certain cysts that could otherwise be hard to manage.
Hear when a new Serous Cystadenoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.